Thermo Fisher Scientific reported 5% organic growth, surpassing consensus by 2 percentage points, prompting management to raise its full-year growth forecast. Mettler-Toledo's local-currency sales grew 6%, exceeding its previous 3% guidance. TEVA also raised guidance for all three of its brands, while Lilly showed strong financial performance with a 48% revenue increase in Q2. These results reinforce confidence in long-term growth, including UnitedHealth's projected 13% to 16% earnings-per-share growth. The positive outlook from these healthcare companies highlights robust sector momentum.
UnitedHealth Group (UNH) shares are trading at USD 418.70 on Pluang as of Oct 26, 2026 15:11 WIB, showing a modest 0.15% increase for the day. Eli Lilly (LLY) is priced at USD 1,280.29 with a 0.54% gain on the same platform and time. These steady price movements complement the positive earnings outlook highlighted in the healthcare sector news.
The Schwab US Dividend Equity ETF (SCHD) has delivered strong price returns of 33% over the past year, yet its dividend income has grown only modestly by about 2%. The fund's top holdings, including Qualcomm, Texas Instruments, UnitedHealth, and Coca...
UnitedHealth Group is focused on expanding its operating margins rather than growing revenue, with margins expected to rebound to 7.8–8.0% by 2030. This improvement is driven by repricing strategies, Medicaid rate adjustments, and restructuring withi...
The Schwab U.S. Dividend Equity ETF (SCHD) has grown to nearly $95 billion in assets, attracting retirees with a 3.2% dividend yield from a portfolio of financially strong companies. Its top holdings include Qualcomm, UnitedHealth, Coca-Cola, and Tex...
